FDA clears safety test to screen Tysabri patients
Friday, January 20, 2012 - 16:30
in Health & Medicine
WASHINGTON (AP) -- The Food and Drug Administration says it has approved a new diagnostic test to help identify patients who have an increased risk of developing a rare brain infection while taking Biogen Idec's multiple sclerosis drug Tysabri....